Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays

Robert Hendrickson, Anthony P. Morocco

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Quetiapine is an atypical antipsychotic agent with structural similarities to the tricyclic antidepressants (TCA). We report a case of quetiapine overdose that was initially clinically similar to that of a TCA overdose and caused a false-positive TCA immunoassay. We then analyzed three common TCA immunoassays [Microgenics (formerly Diagnostic Reagents, Inc.) Tricyclics Serum Tox EIA Assay, Syva® RapidTest d.a.u.®, and Biosite Triage® Panel for Drugs of Abuse] with quetiapine in solution as well as urine from both an overdose patient and a therapeutic patient. There was significant variation of the cutoff of false-positivity in all three immunoassays. Both the Syva® and Microgenics® immunoassays tested positive in both the overdose and therapeutic samples and were positive at urine levels of 100 μg/mL and 10 μg/mL, respectively. The Triage® immunoassay was negative in solutions up to 1000 μg/mL and negative in both the therapeutic and overdose urine samples. Quetiapine may cause false-positive TCA immunoassay with both therapeutic use and in overdose. Significant variation exists between immunoassays to detect quetiapine as a false-positive test.

Original languageEnglish (US)
Pages (from-to)105-108
Number of pages4
JournalJournal of Toxicology - Clinical Toxicology
Volume41
Issue number2
DOIs
StatePublished - 2003

Fingerprint

Tricyclic Antidepressive Agents
Immunoassay
Triage
Urine
Street Drugs
Antipsychotic Agents
Assays
Therapeutic Uses
Quetiapine Fumarate
Therapeutics
Serum

Keywords

  • False-positive
  • Overdose
  • Quetiapine
  • Tricyclic antidepressants
  • Urine tests

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays. / Hendrickson, Robert; Morocco, Anthony P.

In: Journal of Toxicology - Clinical Toxicology, Vol. 41, No. 2, 2003, p. 105-108.

Research output: Contribution to journalArticle

@article{d297c8b24f6d43798556f4114de158f1,
title = "Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays",
abstract = "Quetiapine is an atypical antipsychotic agent with structural similarities to the tricyclic antidepressants (TCA). We report a case of quetiapine overdose that was initially clinically similar to that of a TCA overdose and caused a false-positive TCA immunoassay. We then analyzed three common TCA immunoassays [Microgenics (formerly Diagnostic Reagents, Inc.) Tricyclics Serum Tox EIA Assay, Syva{\circledR} RapidTest d.a.u.{\circledR}, and Biosite Triage{\circledR} Panel for Drugs of Abuse] with quetiapine in solution as well as urine from both an overdose patient and a therapeutic patient. There was significant variation of the cutoff of false-positivity in all three immunoassays. Both the Syva{\circledR} and Microgenics{\circledR} immunoassays tested positive in both the overdose and therapeutic samples and were positive at urine levels of 100 μg/mL and 10 μg/mL, respectively. The Triage{\circledR} immunoassay was negative in solutions up to 1000 μg/mL and negative in both the therapeutic and overdose urine samples. Quetiapine may cause false-positive TCA immunoassay with both therapeutic use and in overdose. Significant variation exists between immunoassays to detect quetiapine as a false-positive test.",
keywords = "False-positive, Overdose, Quetiapine, Tricyclic antidepressants, Urine tests",
author = "Robert Hendrickson and Morocco, {Anthony P.}",
year = "2003",
doi = "10.1081/CLT-120019122",
language = "English (US)",
volume = "41",
pages = "105--108",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays

AU - Hendrickson, Robert

AU - Morocco, Anthony P.

PY - 2003

Y1 - 2003

N2 - Quetiapine is an atypical antipsychotic agent with structural similarities to the tricyclic antidepressants (TCA). We report a case of quetiapine overdose that was initially clinically similar to that of a TCA overdose and caused a false-positive TCA immunoassay. We then analyzed three common TCA immunoassays [Microgenics (formerly Diagnostic Reagents, Inc.) Tricyclics Serum Tox EIA Assay, Syva® RapidTest d.a.u.®, and Biosite Triage® Panel for Drugs of Abuse] with quetiapine in solution as well as urine from both an overdose patient and a therapeutic patient. There was significant variation of the cutoff of false-positivity in all three immunoassays. Both the Syva® and Microgenics® immunoassays tested positive in both the overdose and therapeutic samples and were positive at urine levels of 100 μg/mL and 10 μg/mL, respectively. The Triage® immunoassay was negative in solutions up to 1000 μg/mL and negative in both the therapeutic and overdose urine samples. Quetiapine may cause false-positive TCA immunoassay with both therapeutic use and in overdose. Significant variation exists between immunoassays to detect quetiapine as a false-positive test.

AB - Quetiapine is an atypical antipsychotic agent with structural similarities to the tricyclic antidepressants (TCA). We report a case of quetiapine overdose that was initially clinically similar to that of a TCA overdose and caused a false-positive TCA immunoassay. We then analyzed three common TCA immunoassays [Microgenics (formerly Diagnostic Reagents, Inc.) Tricyclics Serum Tox EIA Assay, Syva® RapidTest d.a.u.®, and Biosite Triage® Panel for Drugs of Abuse] with quetiapine in solution as well as urine from both an overdose patient and a therapeutic patient. There was significant variation of the cutoff of false-positivity in all three immunoassays. Both the Syva® and Microgenics® immunoassays tested positive in both the overdose and therapeutic samples and were positive at urine levels of 100 μg/mL and 10 μg/mL, respectively. The Triage® immunoassay was negative in solutions up to 1000 μg/mL and negative in both the therapeutic and overdose urine samples. Quetiapine may cause false-positive TCA immunoassay with both therapeutic use and in overdose. Significant variation exists between immunoassays to detect quetiapine as a false-positive test.

KW - False-positive

KW - Overdose

KW - Quetiapine

KW - Tricyclic antidepressants

KW - Urine tests

UR - http://www.scopus.com/inward/record.url?scp=0037273041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037273041&partnerID=8YFLogxK

U2 - 10.1081/CLT-120019122

DO - 10.1081/CLT-120019122

M3 - Article

C2 - 12733845

AN - SCOPUS:0037273041

VL - 41

SP - 105

EP - 108

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 2

ER -